You no longer need $25,000 to day trade. The bad news? You'll probably still lose it all.

One Washington metro area ranked in the top 10 most dangerous places to drive during spring, according to a study analyzing a decade of U.S. traffic fatalities.

According to a study published on October 28 in the Proceedings of the National Academy of Sciences, the ice is about 6 million years old. Tiny air bubbles sealed within the ice provide a rare and ...

If you're wondering how to drift in Forza Horizon 6, we don't blame you, because the series' latest entry is set in Japan, the home of drifting. As such, a lot of the game revolves around it, from the ...

While speaking to HT Digital about her preparation journey, Sonakshi revealed her timetable, daily routine, subjects she loved and hated and her future plans.

The deadly hantavirus behind a cruise outbreak that’s thought to have sickened at least 10 people and killed three of them may be transmissible through numerous bodily fluids ranging from saliva to ...

Mars’ frozen ice caps may be time capsules for ancient life. Lab experiments show that key building blocks of proteins can survive tens of millions of years in pure ice, even under relentless cosmic ...

The largest study ever of school cellphone bans finds that they offer decidedly mixed results, with teachers reporting fewer distractions when students lock their phones away during the school day, ...

I’d like to propose a toast, and maybe say a little prayer, for 77 elderly people who agreed to donate their brains to science after they died. Because the fact that they chose to do so might lead to ...

Now that tax season is over, you’re probably tempted to not think about taxes again until next year. That could be a costly mistake. Asking the right questions throughout the year could help you ...

A man convicted of kidnapping a six-year-old girl outside her northeast Miami-Dade home has been sentenced to 30 years in prison. Last November, Leonardo Venegas, 35, was found guilty of kidnapping ...

Long-Term Efficacy and Safety of Taletrectinib in Patients With ROS1+ Non–Small Cell Lung Cancer: Results From the Phase II TRUST-I Study SGNB6A-001 is an open ...